Public Announcement Concerning a Proposed Health Care Project
Baystate Health intends to file a Notice of Determination of Need Application with the Mass. Dept. of Public Health with respect to a Proposed Project involving Trinity Health Of New England’s Mercy Medical Center.
This phase II trial studies how well olaparib and cediranib maleate work in treating patients with endometrial cancer that has come back (recurrent), does not respond to treatment (refractory), or has spread to other places in the body (metastatic). Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
